AstraZeneca to run more clinical trials in people’s homes to improve diversity

Experts say shifting data collection to the home may break down barriers to participation in research

AstraZeneca is to let more people take part in clinical trials from the comfort of their own homes in an attempt to increase the diversity of participants.

Recruiting volunteers to clinical trials can be difficult, but they are a crucial step in the development of new drugs, tests, devices and other interventions.